Tammy Lynn Porter, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 163 Veterans Dr, White River Junction, VT 05009 Phone: 802-295-9363 |
Patricia Gray, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Mulberry Ln, White River Junction, VT 05001 Phone: 386-523-6469 |
Daniel Charles Bartlett, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1200 Christian St, White River Junction, VT 05001 Phone: 802-295-7511 |
Maria Shontz, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 163 Veterans Dr, White River Junction, VT 05009 Phone: 802-295-9363 |
Laura A Smith, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 Fax: 802-296-5153 |
Heather Janine Fenner, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 |
Abigail Grote Olivier, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 163 Veterans Dr, White River Junction, VT 05009 Phone: 802-295-9366 |
Dorothy May Fuller, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 215 N Main St, White River Junction, VT 05009 Phone: 802-295-9363 |
Peter Joseph Bill, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 215 N Main St, White River Junction, VT 05001 Phone: 802-295-9363 |
News Archive
TechPrecision Corporation (OTC Bulletin Board: TPCS) ("TechPrecision", or "the Company"), a leading manufacturer of large-scale, high-precision machined metal fabrications with customers in the alternative energy, medical, nuclear, defense, aerospace and other commercial industries, today released the following open letter to shareholders reviewing the highlights of 2009 and providing an overview of the Company's strategic plan and outlook for 2010.
Arch Pharmalabs, Ltd., a leading provider of small molecule process R&D and full life-cycle custom synthesis and manufacturing services, announced today it has entered into a strategic partnership with Orochem Technologies, Inc., to manufacture a U.S. innovator's active pharmaceutical ingredient (API) in late-stage clinical development using Simulated Moving Bed (SMB) technology.
The second of two studies on latrepirdine, recently published in Molecular Psychiatry, demonstrates new potential for the compound in the treatment of Alzheimer's disease, Parkinson's disease, sleep disorders, and other neurodegenerative conditions. An international team led by Mount Sinai School of Medicine scientists found that latrepiridine, known commercially as Dimebon, reduced the level of at least two neurodegeneration-related proteins in mice.
Research reported in the October issue of The Journal of Nuclear Medicine (JNM) shows that a molecular imaging technique may prove useful in early assessment of treatment response for cisplatin-resistant ovarian cancer.
› Verified 1 days ago